News

Generics reduce costs and increase access

Published on 2016/09/21

Generics reduce costs for both patients and payers and increase patient’s access to medicines, according to a report by the Germany-based Institute for Healthcare and Social Research (IGES). ...

6 views

Read more →

Use of generics in cardiovascular diseases

Published on 2016/09/19

Researchers from Italy and the US carried out a meta-analysis with the aim of comparing the efficacy and adverse events, either serious or mild/moderate, of all generic versus brand-name cardiovas...

19 views

Read more →

Non-biological complex drug concept: experiences with iron sucrose and low molecular weight heparin

Published on 2015/08/25

When the patent of a classical small molecule drug expires, generics may be marketed if their therapeutic equivalence to the originator drug has been established. The therapeutic equivalence of a ...

11 views

Read more →

Canada’s generics are too expensive

Published on 2015/08/21

The same generics cost more in Canada than they do in similarly developed countries. In response to this, the premiers of each Canadian province recently agreed to lower the price of six expensive...

8 views

Read more →

Extrapolation of indications in biosimilars: epoetin

Published on 2015/08/19

Despite a stringent approval process, acceptance of biosimilars in the medical community continues to be low, and especially in extrapolated* indications. Members of the European Medicines Agency'...

17 views

Read more →

Use of biosimilars in rheumatology

Published on 2015/08/17

In order to issue a position statement on the use of biosimilars in rheumatic diseases, the Sociedade Portuguesa de Reumatologia (Portuguese Society of Rheumatology) carried out two systematic li...

30 views

Read more →

Irish pharmacists’ perceptions and attitudes towards generics

Published on 2015/08/13

In June 2013, new legislation came into effect in Ireland - the Health (Pricing and Supply of Medical Goods) Act 2013 - that introduced generics substitution and reference pricing for the first ti...

22 views

Read more →

US biosimilar uptake in the light of Obamacare

Published on 2015/08/11

A literature review by researchers at Tufts University in the US concludes that market uptake of biosimilars in the US will depend on regulatory policies, including the smoothing out of issues con...

2 views

Read more →

Generics losing out to brand-name drugs in Croatia

Published on 2015/08/07

A combination of weak national guidelines and powerful marketing by the pharmaceutical industry has led to a rise in brand-name over generics prescriptions for psychopharmaceuticals in Croatia. ...

10 views

Read more →

Comparison of biosimilar filgrastim versus other G-CSF formulations after autologous stem cell transplantation

Published on 2015/08/05

Introduction Only limited data have been so far published about the use of biosimilar filgrastim in haematologic recovery after autologous stem cell transplantation (ASCT). Despite the limitation...

17 views

Read more →

Extrapolation of indications in biosimilars: filgrastim

Published on 2015/08/03

Extrapolation* of indications for biosimilars is a contentious issue and has been met with concern by physicians. Members of the European Medicines Agency's (EMA) Biosimilar Medicinal Products Wor...

9 views

Read more →

Biosimilars use in Europe varies widely

Published on 2015/07/30

Use of biosimilars in Europe varies widely between countries and therapy areas, according to a report published by IMS Health in October 2014. Biologicals currently account for 27% of pha...

16 views

Read more →